TokenPost·
Moderna Shares Plunge 26% After Melanoma Vaccine Data Leak
-26%
Moderna share drop
The stock closed down 17.57%. The Phase 3 results showed lower risks of melanoma recurrence or death and distant metastasis or death.
More news
- TokenPostCardano Academy Adds eUTxO Session to University of Nicosia Course
- TokenPostStrive Declares First SATS Dividend After Closing $630 Million Offering
- TokenPostPalantir Executive Says NATO’s Maven System Has No Remote Kill Switch
- TokenPostVenice Lists Mercury 3 for API Use With Prompts Visible to Providers
- TokenPostU.S. Banks Limit Outside AI Agents as Most Move Toward Read-Only Access
- CoinGapeEthereum Delays Glamsterdam Hoodi Upgrade Over EIP-8037 Risks